F:NYSE

Ford Motor Company

Data as of 2026-03-10 - not real-time

$12.19

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Ford (F) trades at $12.19, just above the technical support of $11.80, with a 30‑day volatility of roughly 34% and a beta under 1, indicating modest market sensitivity. The 14‑day RSI hovers near 31, suggesting the stock is approaching oversold territory, while the MACD remains bearish, pointing to short‑term downside pressure. Recent earnings missed estimates, reporting EPS of $0.13 versus the $0.18 consensus, and revenue fell 4.8% year‑over‑year, which has weighed on sentiment. A sizable recall affecting 4.4 million vehicles adds a near‑term cost headwind, but the company’s operating cash flow of $21.3 bn and free cash flow of $1.76 bn support the declared dividend of 15 cents per share, yielding about 4.9% with a payout ratio near 64%. Forward‑looking metrics look more attractive: a forward P/E of 6.6, a price‑to‑book of 1.35, and an analyst consensus upside of roughly 16% against a $14‑midpoint target. BofA’s reinstated coverage with a $17 price objective underscores potential upside driven by EV initiatives and regulatory tailwinds.
Given the blend of a high dividend yield, solid cash generation, and a valuation that appears cheap relative to forward earnings, the stock presents a value‑oriented opportunity, though execution risk remains high due to negative margins, a heavy debt load (debt‑to‑equity > 460) and ongoing quality concerns. The medium‑term outlook improves if Ford can translate its EV roadmap into revenue growth and contain recall‑related expenses, while the long‑term case hinges on sustained cash flow to service debt and maintain dividend payouts.

Trading Recommendations

Short Term

< 1 year
hold
Conviction: 5/10

Key Factors

  • Recent earnings miss and recall cost pressures
  • Technical oversold signal (RSI ~31) near support
  • Attractive dividend yield offsetting near‑term uncertainty

Medium Term

1–3 years
buy
Conviction: 7/10

Key Factors

  • Forward P/E of 6.6 indicating cheap valuation
  • Analyst upside potential (~16%) and BofA $17 target
  • Strong cash flow supporting dividend and debt servicing

Long Term

> 3 years
hold
Conviction: 6/10

Key Factors

  • EV and regulatory tailwinds offering growth upside
  • High debt load and negative operating margins limiting upside
  • Sustained dividend payout contingent on cash flow stability

Key Metrics & Analysis

Financial Health

Revenue Growth-4.80%
Profit Margin-4.37%
P/E Ratio6.6
ROE-20.19%
ROA-0.13%
Debt/Equity460.64
P/B Ratio1.4
Op. Cash Flow$21.3B
Free Cash Flow$1.8B

Technical Analysis

TrendNeutral
RSI30.9
Support$11.80
Resistance$14.80
MA 20$13.56
MA 50$13.64
MA 200$12.30
MACDBearish
VolumeStable
Fear & Greed Index75.89

Valuation

Target Price$14.14
Upside/Downside15.98%
GradeUndervalued
TypeValue
Dividend Yield4.92%

Risk Assessment

Beta0.87
Volatility33.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.